A NEW BCL‐2 INHIBITOR (S55746/BCL201) AS MONOTHERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY NON‐HODGKIN LYMPHOMA: PRELIMINARY RESULTS OF THE FIRST‐IN‐HUMAN STUDY. (June 2017) - Le Gouill, S.; Wermke, M.; Morschhauser, F.; Lim, S.T.; Salles, G.; Kloos, I.; de Burgat, V.; Becquart, M.; Paux, G.; Kraus‐Berthier, L.; Pennaforte, S.; Stilgenbauer, S.; et al.